Rtw Investments, LP Axsome Therapeutics, Inc. Transaction History

Rtw Investments, LP

$7.48 Billion
Q3 2025

A detailed history of Rtw Investments, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,118,883 shares of AXSM stock, worth $156 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares

1,118,883

Previous 1,516,903 26.24%

Holding current value

$156 Million

Previous $158 Million 14.18%

% of portfolio

1.82%

Previous 2.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$100.39 - $129.29 $40 Million - $51.5 Million	-398,020 Reduced 26.24%	1,118,883 $136 Million
Q2 2025 Aug 14, 2025	SELL	$95.65 - $116.49 $134 Million - $164 Million	-1,405,826 Reduced 48.1%	1,516,903 $158 Million
Q1 2025 May 15, 2025	SELL	$80.05 - $137.75 $90.3 Million - $155 Million	-1,128,636 Reduced 27.86%	2,922,729 $341 Million
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $11.5 Million - $13.9 Million	-138,192 Reduced 3.3%	4,051,365 $343 Million
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $35.1 Million - $42.6 Million	-444,774 Reduced 9.6%	4,189,557 $376 Million

Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $9.31 Million - $11.4 Million	141,652 Added 3.15%	4,634,331 $373 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $213,929 - $301,024	3,083 Added 0.07%	4,492,679 $359 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $14.2 Million - $16.9 Million	205,319 Added 4.79%	4,489,596 $314 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $29.4 Million - $45.5 Million	503,422 Added 13.32%	4,284,277 $308 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $46.7 Million - $60 Million	800,373 Added 26.85%	3,780,855 $233 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $43.9 Million - $87.6 Million	1,098,318 Added 58.35%	2,980,482 $230 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $9.5 Million - $18.4 Million	263,345 Added 16.27%	1,882,164 $84 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $71,285 - $100,681	2,322 Added 0.14%	1,618,819 $61.2 Million
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $3.13 Million - $4.55 Million	-55,919 Reduced 3.34%	1,616,497 $91.5 Million
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $98,006 - $127,876	1,478 Added 0.09%	1,672,416 $136 Million
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $862,587 - $1.08 Million	12,622 Added 0.76%	1,670,938 $119 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $30.2 Million - $59.7 Million	605,347 Added 57.49%	1,658,316 $136 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $1.08 Million - $2.65 Million	26,156 Added 2.55%	1,052,969 $61.9 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $3.02 Million - $19.2 Million	180,692 Added 21.36%	1,026,813 $106 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $37,079 - $53,421	1,832 Added 0.22%	846,121 $17.1 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $3.35 Million - $6.4 Million	248,654 Added 41.75%	844,289 $21.7 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $1.57 Million - $9.73 Million	595,635 New	595,635 $8.48 Million

Others Institutions Holding AXSM

# of Institutions

414

Shares Held

36.8M

Call Options Held

752K

Put Options Held

567K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Axsome Therapeutics, Inc. Transaction History